// App-Quantinova.ai

45 : Comparison of Outcomes of Unrelated BM and CB Transplants in Young Adult Leukemia Patients. Updated Results of Japanese Registration Study

Researchers

Presenter

  • Seitaro Terakura

Principal Investigators

  • Yoshiko Atsuta

  • Nobuhiro Tsukada

  • Yasuo Morishima

  • Koichi Miyamura

  • Takeshi Kobayashi

  • Masatsugu Tanaka

  • Junya Kanda

  • Kazuteru Ohashi

  • Takahiro Fukuda

  • Naoyuki Uchida

  • Takahashi Satoshi

  • Tokiko Nagamura-Inoue

Medical Centers

  • Department of Hematology, Toranomon Hospital, Tokyo, Japan

  • Department of Surgical Oncology, Japanese Red Cross Medical Center, Tokyo, Japan

  • Department of Surgical Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan

  • Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital,

  • Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Japan

  • Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan

  • Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan

  • The Japan Society for Hematopoietic Cell Transplantation, Nagoya, Japan

  • Department of Cell Processing and Transfusion, Research Hospital, The Institute of Medical Science, The University of Tokyo,

  • Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan

  • Japanese Red Cross Nagoya First Hospital, Nagoya, Japan

  • Div. of Molecular Therapy, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved